These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34601198)

  • 1. Macrophage-derived implantable vaccine prevents postsurgical tumor recurrence.
    Wang D; Xue M; Chen J; Chen H; Liu J; Li Q; Xie Y; Hu Y; Ni Y; Zhou Q
    Biomaterials; 2021 Nov; 278():121161. PubMed ID: 34601198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth.
    Shan H; Dou W; Zhang Y; Qi M
    Nanoscale; 2020 Nov; 12(43):22268-22280. PubMed ID: 33146206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors.
    Wang H; Najibi AJ; Sobral MC; Seo BR; Lee JY; Wu D; Li AW; Verbeke CS; Mooney DJ
    Nat Commun; 2020 Nov; 11(1):5696. PubMed ID: 33173046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy.
    Phuengkham H; Song C; Um SH; Lim YT
    Adv Mater; 2018 May; 30(18):e1706719. PubMed ID: 29572968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gel implant for postsurgical wound management and extended chemoimmunotherapy against breast cancer recurrence.
    Wang M; Wang S; Pan Y; Yu R; Zhang ZR; Fu Y
    Acta Biomater; 2022 Jan; 138():168-181. PubMed ID: 34755605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical tumor-derived nanoplatform targets tumor-associated macrophage for personalized postsurgical cancer immunotherapy.
    Qiao G; Li S; Pan X; Xie P; Peng R; Huang X; He M; Jiang J; Chu X
    Sci Adv; 2024 Mar; 10(13):eadk7955. PubMed ID: 38536926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Microenvironment-Activated Hydrogel Platform with Programmed Release Property Evokes a Cascade-Amplified Immune Response against Tumor Growth, Metastasis and Recurrence.
    Gong S; Liang X; Zhang M; Li L; He T; Yuan Y; Li X; Liu F; Yang X; Shen M; Wu Q; Gong C
    Small; 2022 Dec; 18(50):e2107061. PubMed ID: 36323618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Macrophages as Target for Antitumor Therapy.
    Sawa-Wejksza K; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
    Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
    ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment.
    Zhao H; Zhao B; Wu L; Xiao H; Ding K; Zheng C; Song Q; Sun L; Wang L; Zhang Z
    ACS Nano; 2019 Nov; 13(11):12553-12566. PubMed ID: 31689085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment.
    Lv F; Liu H; Zhao G; Zhao E; Yan H; Che R; Yang X; Zhou X; Zhang J; Liang XJ; Li Z
    iScience; 2022 Jan; 25(1):103639. PubMed ID: 35024580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
    Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
    J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunity.
    Qian H; Zhou T; Fu Y; Guo M; Yang W; Zhang D; Fang W; Yao M; Shi H; Chai C; Cheng W; Ding S; Chen T
    Mol Ther Nucleic Acids; 2022 Mar; 27():763-773. PubMed ID: 35116188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
    Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering Macrophages for Cancer Immunotherapy and Drug Delivery.
    Xia Y; Rao L; Yao H; Wang Z; Ning P; Chen X
    Adv Mater; 2020 Oct; 32(40):e2002054. PubMed ID: 32856350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric Peptide Engineered Bioregulator for Metastatic Tumor Immunotherapy through Macrophage Polarization and Phagocytosis Restoration.
    Chen XY; Yan MY; Liu Q; Yu BX; Cen Y; Li SY
    ACS Nano; 2023 Aug; 17(16):16056-16068. PubMed ID: 37578051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
    Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
    Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.